NCT03880643View on ClinicalTrials.gov

Rituximab in Refractory Primary Membranous Nephropathy

CompletedOBSERVATIONAL

Enrollment

36

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

September 30, 2019

Conditions

Glomerulonephritis, Membranous

Trial Locations (1)

Unknown

Istanbul University, Istanbul

All Listed Sponsors

lead

Istanbul University

OTHER

NCT03880643 - Rituximab in Refractory Primary Membranous Nephropathy | Biotech Hunter | Biotech Hunter